Dr. Mark Shahin, MD
Claim this profileAsplundh Cancer Pavilion
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
19 reported clinical trials
61 drugs studied
Area of expertise
1Ovarian Cancer
BRCA1 positive
BRCA2 positive
Stage IV
2Fallopian Tube Cancer
Stage IV
BRCA1 positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Mark Shahin, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Mark Shahin, MD
Clinical Trial Related7 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mark Shahin, MD has experience with
- Paclitaxel
- Carboplatin
- Cisplatin
- Capivasertib
- Olaparib
- Cediranib Maleate
Breakdown of trials Mark Shahin, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Carcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Shahin, MD specialize in?
Mark Shahin, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is Mark Shahin, MD currently recruiting for clinical trials?
Yes, Mark Shahin, MD is currently recruiting for 5 clinical trials in Willow Grove Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Mark Shahin, MD has studied deeply?
Yes, Mark Shahin, MD has studied treatments such as Paclitaxel, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Mark Shahin, MD?
Apply for one of the trials that Mark Shahin, MD is conducting.
What is the office address of Mark Shahin, MD?
The office of Mark Shahin, MD is located at: Asplundh Cancer Pavilion, Willow Grove, Pennsylvania 19090 United States. This is the address for their practice at the Asplundh Cancer Pavilion.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.